Retension Pharmaceuticals shares drop in IPO trading debut
Retension Pharmaceuticals’ shares fell in their trading debut after an upsized IPO priced at the midpoint of expectations.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.